{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T04:46:16Z","timestamp":1725597976201},"publisher-location":"Boston, MA","reference-count":26,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781461351856"},{"type":"electronic","value":"9781461506676"}],"license":[{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001]]},"DOI":"10.1007\/978-1-4615-0667-6_84","type":"book-chapter","created":{"date-parts":[[2011,7,27]],"date-time":"2011-07-27T19:23:53Z","timestamp":1311794633000},"page":"551-558","source":"Crossref","is-referenced-by-count":0,"title":["Modelling the Responses to Biological Reactive Intermediates"],"prefix":"10.1007","author":[{"given":"P. J.","family":"van Bladeren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. J. P.","family":"Bogaards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. H. P.","family":"Cnubben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. M.","family":"Hissink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"84_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0041-008X(87)90281-X","volume":"87","author":"ME Andersen","year":"1987","unstructured":"Andersen, M.E., H.J. Clewell, M.L. Gargas, F.A. Smith and R.H. Reitz, 1987, Physiologically-based pharmacokinetics and the risk assessment process for methylene chloride., Toxicol. Appl. Pharmacol, 87, 185\u2013205","journal-title":"Toxicol. Appl. Pharmacol"},{"key":"84_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0163-7258(90)90019-X","volume":"48","author":"M Barry","year":"1990","unstructured":"Barry, M. and J. Feely, Enzyme induction and inhibition, 1990, Pharmac. Ther. 48, 71\u201394","journal-title":"Pharmac. Ther"},{"key":"84_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0009-2797(96)03741-6","volume":"102","author":"JJP Bogaards","year":"1996","unstructured":"Bogaards J.J.P., Venekamp J.C., and van Bladeren P.J. (1996). The biotransformation of isoprene and the two isoprene monoepoxides by human cytochrome P450 enzymes, compared to mouse and rat liver microsomes. Chemico-Biological Interactions\n                102, 169\u2013182.","journal-title":"Chemico-Biological Interactions"},{"key":"84_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0009-2797(98)00094-5","volume":"117","author":"JJP Bogaards","year":"1999","unstructured":"J.J.P. Bogaards, J.C. Venekamp, F.G.C. Salmon, P.J. van Bladeren, (1999) Conjugation of isoprene monoepoxides with glutathione, catalyzed by \u03c7, \u00b5, \u03c0 and \u03b8-class glutathione S-transferases of rat and man. Chem. Biol. Interact 117, 1\u201314","journal-title":"Chem. Biol. Interact"},{"key":"84_CR5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3109\/00498258509045888","volume":"15","author":"M Monte Del","year":"1985","unstructured":"Del Monte M., Citti L. and Gervasi P.G. (1985). Isoprene metabolism by liver microsomal mono-oxygenases. Xenobiotica\n                15, 591\u2013597.","journal-title":"Xenobiotica"},{"key":"84_CR6","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/0009-9236(95)90048-9","volume":"58","author":"U Fuhr","year":"1995","unstructured":"Fuhr, U. and A.L. Kummert, 1995, The fate of naringing in humans: A key to grapefruit juice-drug interactions? Clin. Pharmacol Ther. 58, 365\u2013373","journal-title":"Clin. Pharmacol Ther"},{"key":"84_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1021\/tx00043a001","volume":"8","author":"AR Goeptar","year":"1995","unstructured":"Goeptar, A.R. Commandeur, J.M.M Van Ommen, B. Van Bladeren, P.J. Vermeulen M.P.E. (1995) Metabolism and kinetics of trichloroethylene in relation tot toxicity and carcinogenic Chem. Res. Tox. 8, 3\u201321","journal-title":"Chem. Res. Tox"},{"key":"84_CR8","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/jps.2600721003","volume":"72","author":"LE Gerlowski","year":"1983","unstructured":"Gerlowski, L.E. and R.J. Jain, 1983, Physiologically-based pharmacokinetic modeling: principles and applications., J. Pharm. Sci., 72, 1103-","journal-title":"J. Pharm. Sci"},{"key":"84_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1289\/ehp.908685","volume":"86","author":"PG Gervasi","year":"1990","unstructured":"Gervasi P.G. and Longo V. (1990). Metabolism and Mutagenicity of Isoprene. Environ. Health Perspect\n                86, 85\u201387.","journal-title":"Environ.Health Perspect"},{"key":"84_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/clpt.1991.131","volume":"50","author":"FJ Gonzalez","year":"1991","unstructured":"Gonzalez, F.J. and U.A. Meyer U.A., 1991, Molecular genetics of the debrisoquin-sparteine polymorphism, Clinical Pharmacology and Therapeutics, 50, 233\u2013238","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"84_CR11","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3109\/10409239509083491","volume":"30","author":"JD Hayes","year":"1995","unstructured":"Hayes, J.D. and D.J. Pulford, 1995, The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance, Critical reviews in biochemistry and molecular biology, 30, 445\u2013600","journal-title":"Critical reviews in biochemistry and molecular biology"},{"key":"84_CR12","first-page":"301","volume":"145","author":"AM Hissink","year":"1997","unstructured":"Hissink, A.M., B. van Ommen, J. Kruse and P.J. van Bladeren, 1997, A physiologically-based pharmacokinetic (Pb-PK) model for 1,2-dichlorobenzene linked to two possible parameters of toxicity., Toxicol. Appl. Pharmacol., 145, 301\u2013310","journal-title":"Pharmacol"},{"key":"84_CR13","unstructured":"Hissink, A.M., Wormhoudt, L.W., Sheraratt, P.J., Hayes, J.D., Commandeur, J.N.M., Vermeulen, N.P.E., Van Bladeren, P.J., A physiologically-based pharmacokinetic (PB-PK) model for ethylene dibromide; relevance of extrahepatic metabolism. Food Chem in Tox in press."},{"key":"84_CR14","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/0887-2333(94)90002-7","volume":"8","author":"JB Houston","year":"1994","unstructured":"Houston, J.B., 1994, Relevance of in vitro kinetic parameters to in vivo metabolism of xenobiotics., Toxicology in vitro, 8, 507\u2013512","journal-title":"Toxicology in vitro"},{"key":"84_CR15","first-page":"259","volume":"443","author":"MLPS Iersel Van","year":"1999","unstructured":"Van Iersel, M.L.P.S. Verhagen, H. Van Bladeren, P.J. (1999)The role of biotransformation in dietory (anti) carcinogenesis Mut. Res. 443, 259\u2013270","journal-title":"Res"},{"key":"84_CR16","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1021\/bi00356a051","volume":"25","author":"N Koga","year":"1986","unstructured":"Koga, N., P.B. Inskeep, T.M. Harris and F.P. Guengerich, 1986, The major DNA adduct formed from 1,2dibromoethane.,Biochemistry 25, 2191\u20132198","journal-title":"Biochemistry"},{"key":"84_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0378-4274(85)90196-1","volume":"29","author":"V Longo","year":"1985","unstructured":"Longo V., Citti L. and Gervasi P.G. (1985). Hepatic microsomal metabolism of isoprene in various rodents. Toxicol. Lett\n                29, 33\u201337","journal-title":"Toxicol. Lett"},{"key":"84_CR18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1042\/bj2740409","volume":"274","author":"DJ Meyer","year":"1991","unstructured":"Meyer, D.J., B. Coles, S.E. Pemble, K.S. Gilmore, G.M. Fraser and B. Ketterer, 1991, Theta, a new class of glutathione transferase purified from rat and man. Biochem. J., 274, 409\u2013414","journal-title":"Biochem. J"},{"key":"84_CR19","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/carcin\/16.5.1243","volume":"16","author":"HH Nelson","year":"1995","unstructured":"Nelson H.H., Wiencke J.K., Christiani D.C., Cheng T.J., Zuo Z.F., Schwartz B.S., Lee B.K., Spitz M.R., Wang M, Xu X., and Kelsey K.T. (1995). Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis\n                16, 1243\u20131245.","journal-title":"Carcinogenesis"},{"key":"84_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/019262339602400107","volume":"24","author":"A Parkinson","year":"1996","unstructured":"Parkinson, A., 1996, An overview of current cytochrome P450 technology for assessing the safety and efficay of new materials, Toxicologic pathology, 24, 45\u201357","journal-title":"Toxicologic pathology"},{"key":"84_CR21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1006\/taap.1996.8004","volume":"143","author":"JHTM Ploemen","year":"1997","unstructured":"Ploemen, J.H.T.M., L.W. Wormhoudt, G.R.M.M. Haenen, M.J. Oudshoorn, J.N.M. Commandeur, N.P.E. Vermeulen, I. De Waziers, P.H. Beaune, T. Watanabe and P.J. Van Bladeren, 1997, The use of in vitro metabolic parameters to explore the risk assesment of hazardous compounds\u2022the case of ethylene dibromide. Toxicol.Appl.Pharmacol., 143, 56\u201369","journal-title":"Toxicol.Appl.Pharmacol"},{"key":"84_CR22","first-page":"27","volume":"25","author":"G Smith","year":"1995","unstructured":"Smith G., L.A. Stanley, E. Sim, R.C. Strange and C.R. Wolf, 1995, Metabolic polymorphisms and cancer susceptibility, Cancer Surveys 25, 27\u201365","journal-title":"Cancer Surveys"},{"key":"84_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0009-2797(96)03723-4","volume":"101","author":"LW Wormhoudt","year":"1996","unstructured":"Wormhoudt, L.W., J.H.T.M. Ploemen, I. De Waziers, J.H.M. Commandeur, P.H. Beaune, P.J. Van Bladeren and N.P.E. Vermeulen, 1996, Interindividual variability in the oxidation of 1,2-dibromoethane: use of hetereologously expressed human cytochrome P450 and human liver microsomes. Chem. Biol. Interact., 101, 175\u2013192","journal-title":"Chem. Biol. Interact"},{"key":"84_CR24","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1096\/fasebj.6.2.1537464","volume":"6","author":"CS Yang","year":"1992","unstructured":"Yang C.S., J.F. Brady and J.Y. Hong, 1992, Dietary effects on cytochrome P450, xenobiotic metabolism and toxicity, The FASEB Journal, 6, 737\u2013744","journal-title":"The FASEB Journal"},{"key":"84_CR25","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1042\/bj3000271","volume":"300","author":"S Pemble","year":"1994","unstructured":"Pemble S., Schroeder K.R., Spencer S.R., Meyer D.J., Hallier E., Bolt H.M., Ketterer B. and Taylor J.B. (1994). Human glutathione S-transferase Theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J\n                300, 271\u2013276.","journal-title":"Biochem J"},{"key":"84_CR26","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/carcin\/16.5.1243","volume":"16","author":"HH Nelson","year":"1995","unstructured":"Nelson H.H., Wiencke J.K., Christiani D.C., Cheng T.J., Zuo Z.F., Schwartz B.S., Lee B.K., Spitz M.R., Wang M, Xu X., and Kelsey K.T. (1995). Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis\n                16, 1243\u20131245.","journal-title":"Carcinogenesis"}],"container-title":["Advances in Experimental Medicine and Biology","Biological Reactive Intermediates VI"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4615-0667-6_84","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T01:38:32Z","timestamp":1578533912000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4615-0667-6_84"}},"subtitle":["Establishing the Borderlines of Risk"],"short-title":[],"issued":{"date-parts":[[2001]]},"ISBN":["9781461351856","9781461506676"],"references-count":26,"URL":"https:\/\/doi.org\/10.1007\/978-1-4615-0667-6_84","relation":{},"ISSN":["0065-2598"],"issn-type":[{"type":"print","value":"0065-2598"}],"subject":[],"published":{"date-parts":[[2001]]}}}